Empfohlen
Weitere ähnliche Inhalte
Ähnlich wie Personalized medicine 2016 brochure europe
Ähnlich wie Personalized medicine 2016 brochure europe (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Personalized medicine 2016 brochure europe
- 1. Conference Secretariat 2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA Tel: +1-888-843-8169, Fax: +1-650-618-1417 Email: europersonalizedmedicine@conferenceseries.net Brochure europersonalizedmedicine@conferenceseries.neteurope/ Emphasizing the Knowledge of Personalized Medicine Valencia, Spain July 21-22, 2016 EUROPE 4th European Conference on Genomics and Personalized Medicine
- 2. OMICS International welcomes you to attend the 4th International Conference on Genomic & Personalized Medicine Scheduled during July 21-22, 2016 at Valencia, Spain. We are expecting your valuable participation at Euro Personalized Medicine 2016 highlighting the theme “Emphasizing the Knowledge of Personalized Medicine” along with the scientific program which paves a way to gather visionaries through the research talks and presentations. The ultimate mission of the conference is to put forward many thought provoking the Novel Approaches and Innovations in personalised medicine and healthcare, serves an impulse for the advancement of Molecular Diagnostics, a brief discussion on Protein Biomarkers, special focus on Genetics Informed Personalized Immunotherapy and Stem Cells Therapy as the Future of Personalised Medicine. Personalized Medicine promises many medical innovations, and has the potential to change the way treatments are discovered and used. Euro Personalized Medicine 2016 is a remarkable event which brings together a unique and international mix of Participants from Universities, Institutes, Research and Pharma companies. Come, let’s join together to Emphasize the Knowledge of Personalized Medicine Regards, Euro Personalized Medicine 2016 Operating Committee Invitation europersonalizedmedicine@conferenceseries.net
- 3. OMICS International Journals • 500 Open Access Journals • 21 Day rapid review process • 50000 Editorial team, 30000 Reviewers team • 3.5 Million readers and high visibility • More than 100000 • Publication immediately after acceptance • Quality and quick editorial, review processing Key features • User friendly/feasible website translation of your paper to 50 world’s leading languages • Enhanced feature: Audio version of published paper • Digital articles to share and explore • Sharing option: Social networking enabled • Authors, reviewers and editors are provided with scientific credits OMICS International Conferences • 300+ Conferences all over the World every year • Well organized scientific program • Renowned speakers and scientists across the globe • Poster presentations and world class exhibits • Panel discussions and interactive sessions • B2B meetings • Perfect platform for Global Networking Key features • Presentation by renowned speakers from all over the world • Poster presentations and world class exhibits • Interactive Sessions • Platform for global networking • Connecting scientific community Special Issues All accepted abstracts will be published in respective OMICS Group Journals Each abstract will be provided with digital Object Identifier by About us europersonalizedmedicine@conferenceseries.net
- 4. Personalized medicine therapeutics and Molecular diagnostic have huge opportunities for growth in healthcare and will improve therapeutic effectiveness and reduce the severity of adverse effects approach to drug therapies. The significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Euro Personalized Medicine 2016 • Opportunity to attend the presentations delivered by eminent scientists from all over the world • Selected contributions will be published in following OMICS International Journals • Journal of Pharmacogenomics & Pharmacoproteomics • Journal of Molecular and Genetic Medicine • Journal of Nanomedicine & Nanotechnology • Translational Medicine • Journal of Clinical Case Reports • Participation in sessions on specific topics on which the conference is expected to achieve progress • Global networking: In transferring and exchanging Ideas • Conference brings together Scientific Researchers, Medical Surgeons and Physicians Conference highlights: • Personalized Medicine and its Innovations • Market Strategies and Challenges in Personalised Medicine • Pharmacogenomics: Convergence of Pharmacology and Genomics • Genomics and Personalized Medicine • Genetics of Ebola Outbreak • Approaches to Stem Cells • Nanotechnology: Future of Personalised Medicine • Personalised Medicine in 21st Century • Personalized Drug Therapy • Advances in Molecular Diagnostics • Paths of Biomarkers • Clinical Case Reports • Lifestyle Medicine • Preventive Medicines Highlights europersonalizedmedicine@conferenceseries.net
- 5. europersonalizedmedicine@conferenceseries.net With the motto to “Accelerate Scientific Research” –Conferenceseries LLC has succeeded immensely in bringing together the big brains, industrial giants, renowned speakers and scientists providing them with the platform to collaborate and build research partnership. It’s no exaggeration that we got an opportunity to work with the big names since last three years in the field of personalized Medicine and Molecular Diagnostics such as…. 2015 Vincent Gallicchio, Clemson University, USA Ananda Prasad, Wayne State University, USA Anatoly V Skalny, Trace Element Institute for UNESCO, France Constantin Polychronakos, McGill University, Canada Jang-Ung, School of Material Science and Engineering, South Korea Adrián Llerena, RIBEF Ibero-Latinoamerican Network of Pharmacogenetics, Spain Cecilia Gelfi, University of Milano, Italy Iris Lavon, Hadassah Hebrew University, Israel Sangeeta Shukla, Vice Chancellor Jiwaji University, India Kenney-Herbert Emma, Cambridge University, UK Mohamed Abdulla, Primary care center, Sweden Sangeeta Shukla, Jiwaji University, India Maria Angeles Pajares, Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Spain David Cheng, Sidra Medical and Research Center, Qatar Sadhana Shrivastava, Jiwaji University, India Jean Gabert, Hopitaux de Marseille, France Manuel Perez Alonso, University of Valencia Science Park, Spain Lars Von Olleschik-Elbheim, ACON Laboratories, Germany Guilherme Martins Santos, University of Brasilia, Brasilia Lars Von Olleschik-Elbheim, ACON Laboratories, Germany Reda Mohamed Elbadawy, Banha University Faculty of Medicine, Egypt Guo-Hui Fu, Shanghai Jiao Tong University, China Maysa Kamal Salama, Cairo University, Egypt Yin Hua Zhang, Seoul National University, South Korea Fika Atroshi, Rinnekoti Research Center, Finland 2014 Vincent Gallicchio, Clemson University, USA Sergey Suchkov, I M Sechenov First Moscow State Medical University, Russia Mukesh Verma, National Cancer Institute, USA Claudio Nicolini, University of Genova, Italy Catherine Brownstein, Boston Children’s Hospital, USA David Cheng, Sidra Medical and Research Center, Qatar Julia Matena, University of Veterinary Medicine, Germany Tao Wu, Shanghai University of Traditional Chinese Medicine, China Alice Zemljic-Harpf, University of California, USA Jing-bin Huang, Guangxi University of Chinese Medicine, China Emil Alexov, Clemson University, USA Hsiu-Ni Kung, National Taiwan University, Taiwan Cristina Patassini, Genetyx S.R.L., Italy Guillermo Barreto, Max Planck Institute for Heart and Lung Research, Germany Mark D Gorrell, University of Sydney, Australia Tereza Jancuskova, CHAMBON, Czech Republic Evgeniya Peshkova, University of Genova, Italy Afaf El-Ansary, King Saud University, Saudi Arabia Abeer Kadry El Zohiery, Ain Shams University, Egypt Emmanuel C Besa, Thomas Jefferson University, USA Ananda S Prasad, Wayne State University School of Medicine, USA Frank S Ong, Illumina Inc., USA Anton Yuryev, Elsevie, USA Luminita Castillos, Personalized Hematology-Oncology of Wake Forest, USA Jessica Foley, Helen DeVos Children’s Hospital, USA Alireza Hadj Khodabakhshi, Genomic Institute of Novartis Research Foundation, USA Kelvin K Tsai, National Institute of Cancer Research, Taiwan Caroline Diorio, Laval University, Canada Sevtap Savas, Memorial University of Newfoundland, Canada Tahany H Ayaad, King Saud University, Saudi Arabia Wei Xu, University of Toronto, Canada Amir Y Shaik, University of Massachusetts Medical School, University of Massachusetts Medical School Pranay Tanwar, All India Medical Institute, India Guo-HuiFu, Shanghai Jiao Tong University School of Medicine, China Zohreh Mahmoodi, Alborz university of medical sciences, Iran Abdel Kareem Azab, Washington University in Saint Louis School of Medicine, USA Sergey Suchkov, EPMA Member Moscow State Medical University, Russia Trevor G Marshall, Autoimmunity Research Foundation, usa Kirill Shlyapnikov, M Sechenov First Moscow State Medical University, Russia Afaf El-Ansary, King Saud University, Saudi Arabia Saleem Meerani, Steward Carney Hospital, usa 2013 Maurizio Chiriva Internati, Texas Tech University, USA Michael Retsky, Harvard School of Public Health, USA Vincent Gallicchio, UNESCO, USA Toshihisa Ishikawa, RIKEN Omics Science Center, Japan Hans Peter Zenner, University of Tuebingen, Germany Alireza Haghighi, Harvard Medical School, USA Jennifer Rooke, Medical Director of Advanced Lifestyle Medicine, USA Alasdair MacKenzie, University of Aberdeen, UK Takuya Iwamoto, Mie University, Japan Noriko Sato, Tokyo Medical & Dental University, Japan Ann-Marie Chacko, University of Pennsylvania, USA
- 6. Nan Hu, University of Utah, USA Enty Tjoa, University of Indonesia, Indonesia Rong Chen, University of Maryland, USA Subramani Mani, University of New Mexico, USA Fayyad-Kazan Hussein, Universite Libre de Bruxelles, Belgium Hiba A. Awooda, Al Neelain University, Sudan evtap Savas, Memorial University of Newfoundland, Canada Chanderdeep Tandon, Jaypee University of Information Technology, India Margarita Irizarry-Ramirez, University of Puerto Rico, Puerto Rico Xiaojiang Cui, Cedars-Sinai Medical Center, USA Jamboor K.Vishwanatha, UNT Health Science Center, USA Jingfang Ju, Stony Brook University, USA Yong-Chao Ma, Northwestern University, USA Antonio Gomez Munoz, University of the Basque Country, Spain Dik C. Van Gent, Erasmus MC, Netherlands Gerson Chadi, University of Sao Paulo, Brazil B. J. Nickoloff, Michigan State University, USA Fabio Grizzi, Humanitas Clinical and Research, Italy Michael Danquah, Chicago State University, USA Qinwen Mao, Northwestern University Feinberg School of Medicine, USA Ilia Fishbein, University of Pennsylvania, USA Thomas Fritsch, The Wisconsin Parkinson Association, USA immanuel Freedman, GlaxoSmithKline, USA Uri Herzberg, Celgene Cellular Therapeutics, USA Dan Housman, Recombinant By Deloitte, USA Betty Tyler, Johns Hopkins University School of Medicine, USA Jackie Wypij, University of Illinois, USA Ganga Chandramohan, University of California, USA Kazuhiro Aoki, Tokyo Medical and Dental University, Japan Yoshihiro Hataguchi, Ako Kasei co.ltd, Japan Anil S. Modak, Cambridge Isotope Laboratories Inc., USA Mark Gorrell, University of Sydney, Australia Halaris Angelos, Loyola University Medical Center, USA Dik C. Van Gent, Erasmus MC, Netherlands Vladimir A. Kuznetsov, Bioinformatics Institute, Singapore Sin Lee, Chinese Academy of Sciences, China Farooq A. Shiekh, Avalon University school of Medicine, Netherlands Rajesh D Patel, Genentech, USA Douglas K. Price, National Cancer Institute, USA Rihova Blanka, Academy of Sciences of the Czech Republic, Czech Republic Jian-guo Sun, Third Military Medical University, China Hua Fang, University of Chicago, USA Oladipo Aina, Ahmadu Bello University, Nigeria Paul A. Frohna, ProFibrix Inc. & Frohna Biotech Consulting, USA Ena Ray Banerjee, University of Calcutta, India Wanda Sicinska, University of Warsaw, Poland Shu-Feng Zhou, University of South Florida, USA Thomas L. Lenz, Creighton University, USA Richard A. Montagna, Rheonix Inc., USA Madhup Chaurasia, Lincolnshire Clinical Trials Unit, uk Jean Gabert, University Hospital, France David L. Dolinger, Seegene Inc., Republic of Korea Toshihisa Ishikawa, RIKEN Omics Science Center, Japan William R. Ware, University of Western Ontario, Canada Philip Onuoha, University of the West Indies, Trinidad and Tobago For research titles and presentations of above mentioned speakers and delegates visit conference home page and look for the proceedings in the footer. europersonalizedmedicine@conferenceseries.net 2015 Proceedings 2014 2013
- 7. Valencia is the third largest city of Spain with a global city status. Valencia was the 29th fastest improving European city. Its influence in commerce, education, entertainment, media, fashion, science and the arts contributes to its status as one of the world’s “Gamma”-rank global cities. The port city of Valencia is on Spain’s southeastern Orange Blossom Coast, where the Turia River meets the Mediterranean Sea. It’s known for its City of Arts and Sciences, with futuristic structures including a planetarium, an oceanarium and an interactive museum. Valencia also has several beaches, including some within nearby Albufera Park, a wetlands reserve with a lake, walking trails and bird-watching. Valencia is a place where medical institutions, hospitals and clinical research organizations are situated. Therefore it would be a very great place which supports the conference and helps in advancing clinical knowledge and treatment therapy. About Valencia europersonalizedmedicine@conferenceseries.net
- 8. Mail us to know more! For Abstract Submission Guidelines | For Reserving your slot | Proposals | Registration | Posters | Accommodations No doubt you have lots of queries... Why not get in touch..! Drop us your query with details and we will call you right away For Exhibition & Sponsorship queries Contact: Max Steven Email: personalizedmedicine@conferenceseries.net Direct Line: +1-702-508-5200 Extn: 8036 Hosted by OMICS International 2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA Tel: +1-888-843-8169, Fax: +1-650-618-1417 europersonalizedmedicine@conferenceseries.net Contact Us Venue: Valencia, Spain Important Dates Abstract submission opens: October 10, 2015 Registration opens: October 15, 2015 Early Bird Registration: February 22, 2016 Registration: April 25, 2016 Final Registration Date: July 21, 2016